Lyell Immunopharma, Inc. (LYEL) Stock buybacks 2019–2022
Lyell Immunopharma, Inc. (LYEL) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$0FY2022 · since FY2019: $185,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $0 | — |
| FY2021 | $0 | -100.0% |
| FY2020 | $11.8M | +6281.6% |
| FY2019 | $185,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LYEL financial trends
LYEL RevenueLYEL Net incomeLYEL Net marginLYEL Gross profitLYEL Gross marginLYEL Operating incomeLYEL Operating marginLYEL Operating cash flowLYEL Free cash flowLYEL Capital expendituresLYEL Return on equityLYEL Dividends paidLYEL Total assetsLYEL Total liabilitiesLYEL Shareholders’ equityLYEL overview →